Free Trial

BIOX FY2025 EPS Increased by Brookline Capital Management

Bioceres Crop Solutions logo with Consumer Staples background

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) - Stock analysts at Brookline Capital Management increased their FY2025 EPS estimates for Bioceres Crop Solutions in a research note issued to investors on Wednesday, May 21st. Brookline Capital Management analyst K. Dolliver now forecasts that the company will post earnings of $0.04 per share for the year, up from their prior forecast of $0.02. The consensus estimate for Bioceres Crop Solutions' current full-year earnings is ($0.05) per share. Brookline Capital Management also issued estimates for Bioceres Crop Solutions' FY2026 earnings at $0.21 EPS, FY2027 earnings at $0.41 EPS and FY2028 earnings at $0.56 EPS.

A number of other brokerages also recently issued reports on BIOX. Oppenheimer cut their price objective on Bioceres Crop Solutions from $8.00 to $7.00 and set an "outperform" rating for the company in a research report on Tuesday, April 22nd. Canaccord Genuity Group dropped their price target on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a "buy" rating for the company in a research report on Thursday, February 13th. Finally, Lake Street Capital decreased their price objective on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating on the stock in a report on Friday, February 7th. Four research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Buy" and an average target price of $8.63.

Check Out Our Latest Stock Report on Bioceres Crop Solutions

Bioceres Crop Solutions Trading Down 2.1%

NASDAQ:BIOX traded down $0.11 on Monday, reaching $4.86. The company's stock had a trading volume of 2,206 shares, compared to its average volume of 173,470. Bioceres Crop Solutions has a 12-month low of $3.51 and a 12-month high of $11.86. The stock has a 50 day moving average price of $4.40 and a 200 day moving average price of $5.43. The firm has a market cap of $304.46 million, a price-to-earnings ratio of 242.87 and a beta of 0.40. The company has a quick ratio of 0.96, a current ratio of 1.33 and a debt-to-equity ratio of 0.43.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last released its quarterly earnings data on Wednesday, May 21st. The company reported ($0.02) EPS for the quarter, beating analysts' consensus estimates of ($0.10) by $0.08. The firm had revenue of $59.60 million for the quarter, compared to analysts' expectations of $61.80 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.58%.

Institutional Trading of Bioceres Crop Solutions

A number of institutional investors and hedge funds have recently bought and sold shares of BIOX. Jones Financial Companies Lllp boosted its stake in shares of Bioceres Crop Solutions by 3,535.8% in the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company's stock valued at $25,000 after purchasing an additional 5,339 shares during the period. Bank of America Corp DE lifted its holdings in Bioceres Crop Solutions by 186.8% during the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock worth $35,000 after buying an additional 3,735 shares in the last quarter. Jump Financial LLC purchased a new position in Bioceres Crop Solutions in the 4th quarter valued at approximately $72,000. Northern Trust Corp purchased a new position in Bioceres Crop Solutions in the 4th quarter valued at approximately $93,000. Finally, Avanza Fonder AB acquired a new position in shares of Bioceres Crop Solutions in the first quarter worth $72,000. 17.68% of the stock is currently owned by hedge funds and other institutional investors.

Bioceres Crop Solutions Company Profile

(Get Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

Featured Articles

Earnings History and Estimates for Bioceres Crop Solutions (NASDAQ:BIOX)

Should You Invest $1,000 in Bioceres Crop Solutions Right Now?

Before you consider Bioceres Crop Solutions, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.

While Bioceres Crop Solutions currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines